Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07204080) titled '(TNX-1500) in Kidney Transplant Recipients' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ayman Al Jurdi, MD
Condition:
Kidney Transplant
Kidney Transplant Failure and Rejection
Immunosuppression
Immunosuppression After Kidney Transplantation
Intervention:
Drug: TNX-1500
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: January 1, 2026
Target Sample Size: 5
Countries of Recruitment:
United States
To know more, visit https://...